Ms Faiza Bhombal


Digital visual training helps treat disorders associated with close work

Computer software platform provides home vision exercises to overcome asthenopia.

Adam M. Katz, MD


Letter to the Editor: Intravitreal injections. Who should perform them?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.

Dr Claudia Priglinger


First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.

Martin David Harp


AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

Dr Dagny Zhu


Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye disease

A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.

Prof Paolo Vinciguerra


Distorted corneas: How to regularise them with minimally invasive surgery

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations

Ben Shaberman


Gene therapy research ushers in new therapy options for retinal diseases

Foundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.

Professor Winifred Amoaku


Risks and management of diabetic retinopathy in paediatric patients

Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.

Dr Panayiota Founti


The impact of landmark studies on clinical practice in glaucoma

Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.

Dr Paulina Ocieczek


Landscape of genetic therapies for USH2A-related retinitis pigmentosa

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.

Dr Livia Faes


Assessing barriers to retinal care during a pandemic

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.

Joshua P. Harvey, MA, BM BCh, Pg Cert, FRCOphth


The ins and outs of gene therapy for inherited optic neuropathies

A look at what’s in the therapeutic delivery pipeline for these disorders.

Faruk Semiz, MD


Keratoconus: Intrastromal implantation of fresh human lenticules

Stromal regeneration seems possible in patients with keratoconus.

Jai G. Parekh, MD, MBA, FAAO


Paying attention to ocular surface disease preoperatively matters

Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.

Dr Vanita Berry, Prof. Roy A. Quinlan and Prof. Michel Michaelides


Understanding the molecular mechanisms underlying cataract development

A greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.

Dr Brett Mueller


Very-high-frequency ultrasound improves ICL sizing precision

A very-high-frequency ultrasound device provides a range of detailed intraocular measurements that enable highly accurate ICL sizing and placement.

Prof. Navid Ardjomand


How to use topography-guided laser procedures to treat keratoconus

Topography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.

Dr Victor A. Augustin
Dr Victor A. Augustin


Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.

Dr Piotr Kanclerz


Extended depth-of-field IOLs: Clarification of current nomenclature

Clinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.

Dr Antonio Fea


A new route to reducing IOP

To date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.

Dr Manuele Michelessi


Using pivotal study data to guide glaucoma patient management decisions

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.

By Louise Gagnon; Reviewed by Dr Wai-Ching Lam


Surgical management of posterior uveitis in children

Vitrectomy is a tool that can help surgeons curb complications

© 2023 MJH Life Sciences

All rights reserved.